Elaine Caughey
Plus aucun poste en cours
Fortune : 125 463 $ au 30/04/2024
Profil
Elaine Caughey worked as a Director at EndoGastric Solutions, Inc., Head of Strategy & Operations at Biogen, Inc., Financial Analyst at Smith Barney Asset Management, Principal at MPM BioImpact, Inc., Senior Associate at ATV Capital Management Inc., and Consultant at Wilkerson Group.
She is currently the Chief Business Officer at Kymera Therapeutics, Inc. and previously held the same position at Cygnal Therapeutics, Inc. Ms. Caughey received her undergraduate degree from Wellesley College and her MBA from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2023 | 3 762 ( 0,01% ) | 125 463 $ | 30/04/2024 |
Anciens postes connus de Elaine Caughey
| Sociétés | Poste | Fin |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Corporate Officer/Principal | 10/04/2023 |
ATV Capital Management Inc.
 ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts. | Analyste en capital-investissement | 01/03/2007 |
| BIOGEN INC. | Corporate Officer/Principal | - |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
EndoGastric Solutions, Inc.
 EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Directeur/Membre du Conseil | - |
Formation de Elaine Caughey
| Wellesley College | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KYMERA THERAPEUTICS, INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
ATV Capital Management Inc.
ATV Capital Management Inc. Investment ManagersFinance ATV Capital Management Inc. (ATV Capital Management) is a venture capital firm founded in 1979. The firm is headquartered in Boston, Massachusetts. | Finance |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Part of International Business Machines Corp., Wilkerson Group is a consulting company that provides services to the pharmaceutical and medical products industry. The company is based in New York, NY. The company was founded by Kenneth D. Noonan. The CEO is Neil MacAllister. Wilkerson Group was acquired by International Business Machines Corp. on April 01, 1996. | Health Services |
| Smith Barney Asset Management | Finance |
EndoGastric Solutions, Inc.
EndoGastric Solutions, Inc. Medical SpecialtiesHealth Technology EndoGastric Solutions, Inc. develops natural orifice surgical products and procedures to advance the treatment of gastrointestinal diseases. The firm offers EsophyX device and StomaphyX device. The company was founded by Stefan J. M. Kraemer, Clifton A. Alferness, Scott Jordan Wolf, James W. Fitzsimmons and John M. Adams in 2003 and is headquartered in Redmond City, WA. | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA. | Health Technology |